Sunday, March 4, 2012

The dispute of calling for bid at a low price: The basic medicine patent medicine enterprise " The sting in one's heart "

The dispute of calling for bid at a low price: The basic medicine patent medicine enterprise " The sting in one's heart "
"We basically give up the basic medicine now. In the following five years, we are limited to the pricing system that the hospital call for bid with the pricing system of the pharmacy, and so as to construct the whole pricing system of enterprises. " August 20, in the Chinese medicines retail market developed the public lecture in 2011, Wang WenChu, general manager of Limited Company of pharmacy of White Cloud Mountain, expressed the view on the market of non- basic medicine. Except White Cloud Mountain, as far back as the end of the year of 2009, after the national basic medicine will begin to call for bid alone for half a year in the place formally, a gleam of domestic pharmaceuticalses such as Tongrentang Chinese Medicine-Since 1669, one pair of crane's medicine companies suspend the supply one after another. At present, " most low to call for bid price " Spreading in the whole country, the basic medicine has already become " sting in one's heart " of the medical manufacturing company . "Basic the intersection of medicine and national unified price or expected to it solves basic medicines to be most low to call for bid enormous pressure that the price will be caused to medical industry. " Permanent roc of bright red of research center thinks the public policy of institute for economic research of Chinese Academy of Social Sciences. The news of national development and reform committee claims, evaluation centre of the national development and reform committee medicines price has already held the forum of the unified price in Beijing on the 11th, the 12th of August separately, surveying and studying in the main medical enterprises of our country at present, collect the national opinion of unifying the price of basic medicine extensively. This measure means the development and reform committee has already listed unifying the basic medicine price item in the schedule, disclose news to claim, try 41 basic medicine varieties within the year or. Give up base medicine? Another unexpected result of winning a bid at a low price is, low priced medicine out of stock is performed in all parts of the country repeatedly The national unified price of basic medicine spreading promptly at the end of last year has already become the focus. Chinese medicine learn the intersection of medicine and the intersection of economics and professional data of committee reveal some basic medicine of area concentrate on result that bid and purchase, appear " each 12 cow bezoar detoxify slice it marks a price to be only 1, every the intersection of chip and 1 fen less than " even ," the price of 500 ml of large infusion is less than 1 yuan " Extreme phenomenon. Call it in the industry " The medicine price is empty and low " . "Quality risk and brand that the abnormal ultralow biding price may bring injure, the big medical enterprises resulting in paying attention to the brand have to give up profitless basic medicine competitive bidding. " Zhu HengPeng thinks, " this relates to system that the bottom price pursued in Anhui Province win a bid, the whole country have 12 provinces and cities implement mode this at present, in imitated by more local governments. The result of this kind of mode is, enterprises though medicine shines and sells, the sudden drop of the profit. " According to data of State Statistics Bureau, the medical trade income from sales continues keeping growing at top speed in the first half of this year, but the increasing degree of the profit drops rapidly. The national medical income from sales of the first half of the year of manufacturing industry increases by 30.03% compared with the same period of last year, reach 656,331 million yuan; The total profit reaches 65,668 million yuan totally, increase by 21.67% compared with the same period of last year, but compared with 37% of the increasing degree of the same period of 2010, increasing degree for the first half of this year falls 15 percentage points after rise. Among them, the medicine total profit increasing degree of the first five months of listed company is 18.5%, and this data were 69.2% at the same period last year, the fall-back after the rise by a wide margin which presented 50.7 percentage points. The medical business administration association of China will be longer than MingDe to show, the second half of this year, it is still expected to realize the growth of ultra expectancy that medicine is sold, be up to 27%-28%, and profit increasing degree will present the posture of obviously dropping, it is estimated it among 15%-16%. In addition, another unexpected result of winning a bid at a low price is, past cheap medicine all fade from the hospital now, even some common medicine ordinary people can not buy. From the beginning of this year, low priced medicine out of stock is performed in all parts of the country repeatedly. Research and analyse according to HengPeng Zhu, implement basic two year such as system such as medicine, basic the intersection of medicine and the intersection of province and grade concentrate on call for bid, one the intersection of product and one one factory rule, a price differential sell, two lines of revenue and expenditure of medical organization, determine a post and compile and edit the salary definitely, the administrative department examines the performance to medical organization and doctor. "The actual result is, the medical organization still sells medicines the same as the past, its edition of revenue and expenditure +40% of the places of basic medicine editions of 30% of the countries augments +30% of the non- base medicines base medicines. " Zhu HengPeng says, " but the highest bidder of the low price just changes sold the medicine profit mode, not because depended on the originally legal price differential between wholesale and retail, but depended on returning to some and commission. " "If basic medicine unified price, mean the existing basic medicine calls for bid and regards economic technology as the basis that could win a bid, strengthen quality, the big medical manufacturing company will obtain higher winning a bid of the chance, will advance the whole trade to select the superior and eliminate the inferior to develop. " A large-scale medicine listing entrepreneur in our country thinks. The unified price is good fortune or the misfortune " the country should set up a set of unified, quantized comprehensive evaluation index systems " According to the information of development and reform committee, to numerous base medicine varieties of calling for bid, in liberal supply, with steady price, will be made the selling price, confirmed the unified price in unison by the country. But the above-mentioned medicine enterprise personage says, now though the basic medicine unified price is expected to be very strong, unified price good fortune or misfortune to be still too difficult to come to a conclusion to medical industrial enterprise. And does not say medicines regarded as the pilot project at present and have dozens of varieties only, the proportion is very low, realize all uniform prices of base medicine, can not be realized in short term. In addition, on long terms, it is still too difficult to come to a conclusion to the fundamental key of the unified price of basic medicine at present, it is from pricing from low pricing high, the development and reform committee has not taken a stand. If adopt from the principle of low pricing after the national unified price, may consult present winning a bid of the price more low, mean the country is posthumously admitted as present winning a bid of the result. Basic medicine call for bid, price at already for two year, each the intersection of medicines and different regional price have high to have low at present, call for bid price dress than high area to the intersection of low price and district too finally, equal to further drawing the low medicine price of base on the existing foundation. More important, after the national unified price of base medicine, retailing the pharmacy should carry out the standard of this price too. So, if is from the low pricing principle, enterprises have not regulated the room for maneuver of the profit again. Another result is from pricing high. This will make the implementation department of the system very large in pressure. For example medicine medicines of a certain base are 1 yuan in some bid price saved, but it is 1.2 yuan to save in another one, the national uniform price is 1.2 yuan finally, this means calling for bid in the low province of the price, hospital and government want, foot a bill, come out, increase price, check for 0.2 these more, how it coordinates the contradictions to be whether piece wait, solve question development and reform committee. In addition, after implementing the unified price, the basic medicine calls for bid and turns from present method price into and employs qualification, how to define this qualification to receive much concern too. The above-mentioned medicine enterprise personage thinks, the country should set up a set of unified, quantized basic medicine manufacturing enterprises Comprehensive evaluation index system, guarantee only sincere norm, quality are ensured, strong and the pharmacy enterprises of social responsibility could enter the basic medicine and bid and purchase the range.

|

No comments:

Post a Comment